Literature DB >> 9208265

A comparative study of isokinetic dynamometry and manual muscle testing of ankle dorsal and plantar flexors and knee extensors and flexors.

H Andersen1, J Jakobsen.   

Abstract

Muscle strength in neuropathic patients is usually evaluated clinically using manual muscle testing (MMT). Detection and grading of mild symmetrical muscle weakness using MMT is difficult partly because the examiner must take into consideration the normal variation in strength in relation to age, weight, height, and gender. In the present study assessment of the strength of ankle dorsal and plantar flexors and knee flexors and extensors with MMT and isokinetic dynamometry were compared in 108 patients, of whom 86 had diabetes mellitus and 22 had alcoholic liver cirrhosis. The isokinetic muscle strength of the patients was compared with the strength of 90 healthy control subjects, adjusted for the influence of age, weight, and height for both genders. MMT resulted in a significant underestimation of the frequency and severity of muscle weakness in both the ankle and the knee. In 28-41% of the comparisons, MMT misclassified the strength performance with one category or more (> 25%). Misclassifications were most frequent for the ankle plantar flexors.

Entities:  

Mesh:

Year:  1997        PMID: 9208265     DOI: 10.1159/000117450

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  9 in total

1.  Maximal isokinetic and isometric muscle strength of major muscle groups related to age, body mass, height, and sex in 178 healthy subjects.

Authors:  Thomas Harbo; John Brincks; Henning Andersen
Journal:  Eur J Appl Physiol       Date:  2011-05-03       Impact factor: 3.078

2.  Motor Impairment and Its Influence in Gait Velocity and Asymmetry in Community Ambulating Hemiplegic Individuals.

Authors:  Consuelo B Gonzalez-Suarez; Christine Grace V Ogerio; Angelo R Dela Cruz; Edison A Roxas; Belinda C Fidel; Ma Roxanne L Fernandez; Christopher Cruz
Journal:  Arch Rehabil Res Clin Transl       Date:  2020-11-25

Review 3.  Musculoskeletal conditions of the foot and ankle: assessments and treatment options.

Authors:  Smita Rao; Jody L Riskowski; Marian T Hannan
Journal:  Best Pract Res Clin Rheumatol       Date:  2012-06       Impact factor: 4.098

4.  Manual muscle testing and hand-held dynamometry in people with inflammatory myopathy: An intra- and interrater reliability and validity study.

Authors:  Pierrette Baschung Pfister; Eling D de Bruin; Iris Sterkele; Britta Maurer; Rob A de Bie; Ruud H Knols
Journal:  PLoS One       Date:  2018-03-29       Impact factor: 3.240

5.  The Influence of Clinically Diagnosed Neuropathy on Respiratory Muscle Strength in Type 2 Diabetes Mellitus.

Authors:  Birgit L M Van Eetvelde; Dirk Cambier; Karsten Vanden Wyngaert; Bert Celie; Patrick Calders
Journal:  J Diabetes Res       Date:  2018-11-29       Impact factor: 4.011

6.  The Validity and Reliability of Two Commercially Available Load Sensors for Clinical Strength Assessment.

Authors:  Kohle Merry; Christopher Napier; Vivian Chung; Brett C Hannigan; Megan MacPherson; Carlo Menon; Alex Scott
Journal:  Sensors (Basel)       Date:  2021-12-16       Impact factor: 3.576

7.  Interrater and Intrarater Reliability of the EasyForce Dynamometer for Assessment of Maximal Shoulder, Knee and Hip Strength.

Authors:  Nebojša Trajković; Žiga Kozinc; Darjan Smajla; Nejc Šarabon
Journal:  Diagnostics (Basel)       Date:  2022-02-09

8.  Muscle performance and ankle joint mobility in long-term patients with diabetes.

Authors:  Claudia Giacomozzi; Emanuela D'Ambrogi; Stefano Cesinaro; Velio Macellari; Luigi Uccioli
Journal:  BMC Musculoskelet Disord       Date:  2008-07-04       Impact factor: 2.362

9.  Stance Postural Strategies in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

Authors:  Steno Rinalduzzi; Marco Serafini; Marco Capozza; Neri Accornero; Paolo Missori; Carlo Trompetto; Francesco Fattapposta; Antonio Currà
Journal:  PLoS One       Date:  2016-03-15       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.